methyl 5-aminolevulinate has been researched along with imiquimod in 35 studies
| Studies (methyl 5-aminolevulinate) | Trials (methyl 5-aminolevulinate) | Recent Studies (post-2010) (methyl 5-aminolevulinate) | Studies (imiquimod) | Trials (imiquimod) | Recent Studies (post-2010) (imiquimod) |
|---|---|---|---|---|---|
| 524 | 152 | 319 | 3,264 | 284 | 1,963 |
| Protein | Taxonomy | methyl 5-aminolevulinate (IC50) | imiquimod (IC50) |
|---|---|---|---|
| Histamine H2 receptor | Homo sapiens (human) | 1.506 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 2.621 | |
| Adenosine receptor A2a | Homo sapiens (human) | 5.32 | |
| 7,8-dihydro-8-oxoguanine triphosphatase | Homo sapiens (human) | 0.646 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (11.43) | 29.6817 |
| 2010's | 24 (68.57) | 24.3611 |
| 2020's | 7 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brownell, I | 1 |
| Lear, JT; Madan, V; Murphy, JV; West, CA | 1 |
| Calvieri, S; Curzio, M; Devirgiliis, V; Gobbi, S; Panasiti, V; Roberti, V; Rossi, M | 1 |
| Downs, A; Muston, D; Rives, V | 1 |
| Aguilar, M; Benítez, N; de Troya, M; González, M; Martin, L | 1 |
| Chimenti, S; Colombo, GL; Di Matteo, S; Fargnoli, MC; Frascione, P; Peris, K; Silipo, V | 1 |
| Wilson, EC | 1 |
| Goldenberg, G; Skupsky, H; Skupsky, J | 1 |
| Botella-Estrada, R; Guillen, C; Hueso, L; Llombart, B; Nagore, E; Requena, C; Sanmartín, O; Serra-Guillen, C | 1 |
| Fernández Tirado, FJ; García Martín, E | 1 |
| Apalla, Z; Chovarda, E; Goussi, C; Ioannides, D; Lallas, A; Sotiriou, E; Trigoni, A | 1 |
| Botella-Estrada, R; Guillén, C; Hueso, L; Llombart, B; Messeguer, F; Nagore, E; Requena, C; Sanmartín, O; Serra-Guillén, C; Traves, V | 1 |
| Guillén, C; Llombart, B; Messeguer, F; Requena, C; Serra-Guillén, C | 1 |
| Gupta, AK; Paquet, M | 1 |
| Bath-Hextall, FJ; Leonardi-Bee, J; Matin, RN; Wilkinson, D | 1 |
| Apalla, Z; Argenziano, G; Evangelou, G; Ioannides, D; Kyrgidis, A; Lallas, A; Lazaridou, E; Lefaki, I; Patsatsi, A; Sidiropoulos, T; Sotiriou, E; Stratigos, A; Trakatelli, M; Tzellos, T; Zalaudek, I | 1 |
| Arits, AH; Essers, BA; Kelleners-Smeets, NW; Mosterd, K; Nelemans, P; Spoorenberg, E | 1 |
| Arits, AH; Kelleners-Smeets, NW; Mosterd, K; Nelemans, PJ; Roozeboom, MH; Steijlen, PM | 1 |
| Egekvist, H; Erlendsson, AM; Haedersdal, M; Lorentzen, HF; Philipsen, PA; Stausbøl-Grøn, B; Stender, IM | 1 |
| Alkemade, HA; Gerritsen, MJ; Groenewoud, H; Grutters, JP; Maessen-Visch, MB; Seubring, I; van de Kerkhof, PC; van der Wilt, GJ; van Doorn, R; van Rijsingen, MC | 1 |
| Bay, C; Haedersdal, M; Lerche, CM; Togsverd-Bo, K | 1 |
| Gonzalez, H; Haedersdal, M; Halldin, C; Sandberg, C; Sørensen, SS; Togsverd-Bo, K; Wennberg, AM; Wulf, HC | 1 |
| Arits, AHMM; Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJF; Roozeboom, MH; Sommer, A; Steijlen, PM; van Pelt, HPA | 1 |
| Aberbigbe, O; Etzkorn, JR; Neal, DE; Smith, RJ | 1 |
| Calzavara-Pinton, P; Hamon, P; Tanova, N | 1 |
| Arits, AHMM; Hamid, MA; Jansen, MHE; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Roozeboom, MH; van Delft, LCJ | 1 |
| Arits, AHMM; Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Kessels, JPHM; Kouloubis, N; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJF; Steijlen, PM; van Pelt, HPA | 1 |
| Borik, L; Brunner, PM; Geusau, A; Mildner, M; Müllegger, R; Petzelbauer, P; Tzaneva, S | 1 |
| Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Kessels, JPHM; Merks, I; Mosterd, K; Nelemans, PJ | 1 |
| Kulakov, EL; Logan, IT; Perrett, CM | 1 |
| Berking, C; Heppt, MV; Steeb, T | 1 |
| Ali, FR; Raza, SA | 1 |
| Bath-Hextall, FJ; Hogan, S; Leonardi-Bee, J; Thomson, J; Williams, HC | 1 |
| Feldman, SR; Heron, CE | 1 |
| Ahmady, S; Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Kessels, JPHM; Mosterd, K; Nelemans, PJ | 1 |
4 review(s) available for methyl 5-aminolevulinate and imiquimod
| Article | Year |
|---|---|
Disseminated superficial actinic porokeratosis: a treatment review.
Topics: Aminolevulinic Acid; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Cholecalciferol; Diclofenac; Fluorouracil; Humans; Imiquimod; Immunosuppressive Agents; Interferon Inducers; Laser Therapy; Photochemotherapy; Photosensitizing Agents; Porokeratosis; Retinoids; Vitamins | 2012 |
Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review.
Topics: Adjuvants, Immunologic; Aged; Aminolevulinic Acid; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Cryotherapy; Diclofenac; Diterpenes; Drug Combinations; Female; Fluorouracil; Follow-Up Studies; Humans; Hyaluronic Acid; Imiquimod; Immunocompetence; Immunosuppressive Agents; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Randomized Controlled Trials as Topic; Treatment Outcome | 2013 |
Interventions for cutaneous Bowen's disease.
Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Cryotherapy; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2013 |
Interventions for basal cell carcinoma of the skin.
Topics: Adult; Aminolevulinic Acid; Antineoplastic Agents; Carcinoma, Basal Cell; Cryotherapy; Female; Humans; Imiquimod; Immunocompetence; Laser Therapy; Male; Mohs Surgery; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Radiotherapy; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome | 2020 |
9 trial(s) available for methyl 5-aminolevulinate and imiquimod
| Article | Year |
|---|---|
A randomized comparative study of tolerance and satisfaction in the treatment of actinic keratosis of the face and scalp between 5% imiquimod cream and photodynamic therapy with methyl aminolaevulinate.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aminolevulinic Acid; Aminoquinolines; Child; Child, Preschool; Facial Dermatoses; Female; Humans; Imiquimod; Infant; Keratosis, Actinic; Male; Middle Aged; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Young Adult | 2011 |
A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: clinical and histologic outcomes.
Topics: Administration, Topical; Aged; Aminolevulinic Acid; Aminoquinolines; Female; Humans; Imiquimod; Immunocompetence; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Prospective Studies; Treatment Outcome | 2012 |
Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Cost Savings; Cost-Benefit Analysis; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2014 |
Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Ointments; Photochemotherapy; Photosensitizing Agents; Single-Blind Method; Skin Neoplasms; Treatment Outcome | 2015 |
Photodynamic therapy is more effective than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial.
Topics: Aged; Aminolevulinic Acid; Drug Eruptions; Facial Dermatoses; Female; Hand Dermatoses; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Pain; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Treatment Outcome | 2018 |
Randomized Trial of Four Treatment Approaches for Actinic Keratosis.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Diterpenes; Female; Fluorouracil; Follow-Up Studies; Gels; Humans; Imiquimod; Intention to Treat Analysis; Keratosis, Actinic; Male; Middle Aged; Patient Compliance; Photochemotherapy; Photosensitizing Agents; Proportional Hazards Models; Scalp Dermatoses; Single-Blind Method; Skin Cream; Treatment Outcome | 2019 |
Peptidase inhibitor 3 and chemokine ligand 27 may serve as biomarkers for actinic keratoses in organ transplant recipients.
Topics: Administration, Topical; Aged; Aminolevulinic Acid; Biomarkers; Chemokine CCL27; Elafin; Female; Follow-Up Studies; Gene Expression Regulation; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Prospective Studies; Reference Values; RNA, Messenger; Severity of Illness Index; Transplant Recipients; Treatment Outcome | 2019 |
A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherla
Topics: Aminolevulinic Acid; Cost-Benefit Analysis; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Netherlands; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Treatment Outcome | 2020 |
The Effect of Four Approaches to Treat Actinic Keratosis on the Health-Related QOL, as Assessed by the Skindex-29 and Actinic Keratosis QOL.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Diterpenes; Female; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Male; Patient Reported Outcome Measures; Photochemotherapy; Quality of Life; Skin Cream; Surveys and Questionnaires; Treatment Outcome | 2021 |
22 other study(ies) available for methyl 5-aminolevulinate and imiquimod
| Article | Year |
|---|---|
Nodular basal cell carcinoma: when in doubt, cut it out.
Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Mohs Surgery; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Failure | 2007 |
Sequential treatment of giant basal cell carcinomas.
Topics: Administration, Topical; Aged; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2009 |
Complete remission of nodular basal cell carcinoma after combined treatment with photodynamic therapy and imiquimod 5% cream.
Topics: Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Humans; Imiquimod; Male; Ointments; Photochemotherapy; Photosensitizing Agents; Remission Induction; Skin Neoplasms | 2008 |
An economic evaluation of topical treatments for actinic keratosis.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Cost-Benefit Analysis; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Models, Economic; Photochemotherapy; Photosensitizing Agents; Treatment Outcome; United Kingdom | 2009 |
A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen's disease of the lower extremities.
Topics: Aminolevulinic Acid; Aminoquinolines; Bowen's Disease; Carcinoma, Basal Cell; Cost-Benefit Analysis; Humans; Imiquimod; Photochemotherapy; Skin Neoplasms | 2010 |
Cost-effectiveness analysis of topical treatments for actinic keratosis in the perspective of the Italian health care system.
Topics: Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Cost-Benefit Analysis; Decision Trees; Delivery of Health Care; Diclofenac; Health Care Costs; Humans; Imiquimod; Italy; Keratosis, Actinic | 2010 |
Cost effectiveness of imiquimod 5% cream compared with methyl aminolevulinate-based photodynamic therapy in the treatment of non-hyperkeratotic, non-hypertrophic actinic (solar) keratoses: a decision tree model.
Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Cost-Benefit Analysis; Data Interpretation, Statistical; Decision Trees; Humans; Imiquimod; Keratosis, Actinic; Models, Economic; Photochemotherapy; Photosensitizing Agents; Quality-Adjusted Life Years; United Kingdom | 2010 |
[Periocular basal cell carcinoma treatment tendencies].
Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Conjunctival Neoplasms; Eyelid Neoplasms; Humans; Imiquimod; Immunologic Factors; Mohs Surgery; Neoplasms, Radiation-Induced; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Sunlight | 2010 |
Sequential use of photodynamic therapy and imiquimod 5% cream for the treatment of actinic cheilitis: a 12-month follow-up study.
Topics: Administration, Cutaneous; Aged; Aminolevulinic Acid; Aminoquinolines; Cheilitis; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Ointments; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2011 |
Facial extensive recurrent basal cell carcinoma: successful treatment with photodynamic therapy and imiquimod 5% cream.
Topics: Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2012 |
Applicability of dermoscopy for evaluation of patients' response to nonablative therapies for the treatment of superficial basal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Dermoscopy; Humans; Imiquimod; Male; Middle Aged; Neoplasm, Residual; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2014 |
Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cross-Sectional Studies; Cryotherapy; Denmark; Dermatology; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Outpatient Clinics, Hospital; Photochemotherapy; Photosensitizing Agents; Practice Patterns, Physicians'; Private Practice; Sex Factors; Skin Neoplasms | 2016 |
Real-life Data on Patient Characteristics, Cost and Effectiveness of Field-directed Treatment for Actinic Keratoses: An Observational Study.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Cost-Benefit Analysis; Dermatologic Agents; Drug Costs; Female; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Netherlands; Patient Preference; Photochemotherapy; Photosensitizing Agents; Remission Induction; Severity of Illness Index; Time Factors; Treatment Outcome | 2016 |
Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol. An experimental hairless mouse study.
Topics: Aminolevulinic Acid; Aminoquinolines; Animals; Calcitriol; Carcinoma, Squamous Cell; Female; Fluorouracil; Imiquimod; Mice; Mice, Hairless; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin; Skin Neoplasms; Ultraviolet Rays | 2016 |
Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Ointments; Photochemotherapy; Skin Neoplasms | 2018 |
Cells to Surgery Quiz: July 2018.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Antineoplastic Agents; Carcinoma, Basal Cell; Disease-Free Survival; Drug Eruptions; Equivalence Trials as Topic; Face; Fluorouracil; Humans; Imiquimod; Male; Photochemotherapy; Photosensitizing Agents; Skin Cream; Skin Neoplasms; Treatment Outcome | 2018 |
Evaluation of the treatment costs and duration of topical treatments for multiple actinic keratosis based on the area of the cancerization field and not on the number of lesions.
Topics: Administration, Topical; Aminolevulinic Acid; Cohort Studies; Cost of Illness; Diclofenac; Diterpenes; Drug Administration Schedule; Female; Fluorouracil; Health Care Costs; Humans; Imiquimod; Italy; Keratosis, Actinic; Male; Photochemotherapy; Precancerous Conditions; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2019 |
Histologic subtype of treatment failures after noninvasive therapy for superficial basal cell carcinoma: An observational study.
Topics: Aged; Aminolevulinic Acid; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Basal Cell; Equivalence Trials as Topic; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Failure | 2019 |
Sequential Treatment of Superficial Basal Cell Carcinomas With Topical Methyl Aminolevulinate Photodynamic Therapy and Imiquimod 5% Cream: A Retrospective Study of Clinical and Cosmetic Outcomes.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Combined Modality Therapy; Esthetics; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Skin Cream; Skin Neoplasms; Treatment Outcome | 2020 |
Cash is king: the balance of costs and effectiveness of treatments for actinic keratosis.
Topics: Aminolevulinic Acid; Cost-Benefit Analysis; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Netherlands; Photochemotherapy | 2020 |
Comparison of efficacy of field treatments for actinic keratoses.
Topics: Adult; Aminolevulinic Acid; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Scalp Dermatoses | 2020 |
Ingenol Mebutate and the Treatment of Actinic Keratosis.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Clinical Trials as Topic; Diterpenes; Fluorouracil; Humans; Imiquimod; Incidence; Keratosis, Actinic; Patient Preference; Photochemotherapy; Photosensitizing Agents; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2021 |